Allergy Immunotherapy Market Size, Analysis, Key Segments, Share, Growth Status, and Forecast 2030

 

Research Nester published a report titled “Allergy Immunotherapy Market: Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of the global allergy immunotherapy market in terms of market segmentation by treatment, allergy type, distribution channel, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global allergy immunotherapy market is estimated to grow at a CAGR of ~8.7% over the forecast period, i.e., 2022 – 2030. The market is segmented on the basis of allergy type into allergic rhinitis, asthma, allergic conjunctivitis, and others, out of which, the allergic rhinitis segment is estimated to gain the largest market share over the forecast period, owing to the high prevalence of allergic rhinitis in children globally. Moreover, the rapidly increasing awareness for treatment as allergic rhinitis acts as a precursor for other diseases like attention deficit hyperactivity disorder (ADHD), which is estimated to boost the market growth.

Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-3769

The global allergy immunotherapy market is anticipated to grow on the back of increasing occurrence of allergic diseases, backed by the increasing pollution levels, and poor dietary habits. Food allergy, dust allergy, and pollen allergy are the most common kind of allergies, prevalent across the world. According to a report by the U.S. National Library of Medicine, 10% of the population in western countries, is challenge-diagnosed with food allergies. Moreover, the growing demand for the development of efficient immunotherapy procedure is projected to fuel the market growth.

On the basis of geographical analysis, the global allergy immunotherapy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the growing prevalence of allergic conditions in the region. According to the World Allergy Organization, allergic rhinitis affects 10-30% of the general adult population and about 40% of children in the US. Moreover, presence of major pharmaceutical companies in the region, is projected to boost the regional market growth.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Browse full report summary : https://www.researchnester.com/reports/allergy-immunotherapy-market/3769

Increasing Cases of Allergies to Boost the Market Growth

Various factors, such as, rising dust and pollution levels, and poor lifestyle, are causing surge in prevalence of allergies, globally. Allergies can lead to various serious health threats, including asthma, which can be deadly. According to the World Health Organization statistics, asthma affected about 262 million individuals in 2019 worldwide and resulted in 461,000 deaths. Such factors are anticipated to propel the market growth.

However, limitations associated with applicability of allergy immunotherapy are expected to operate as key restraint to the growth of global allergy immunotherapy market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global allergy immunotherapy market which includes company profiling of Allergopharma GmbH, Stallergenes Greer Ltd., HAL Allergy B.V., HollisterStier Allergy (Jubilant Pharma), Torii Pharmaceutical Co.,Ltd, ALK Abelló A/S, Allergy Therapeutics, Allovate, LLC, and Circassia Group PLC. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global allergy immunotherapy market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     

Request Report Sample@ https://www.researchnester.com/sample-request-3769

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919